151
Participants
Start Date
February 17, 2015
Primary Completion Date
August 2, 2017
Study Completion Date
August 2, 2017
Ipatasertib
Ipatasertib will be administered at a dose of 400 milligrams (mg) orally daily on Days 1-21 of each 28-day cycle for 3 cycles.
Paclitaxel
Paclitaxel will be administered at a dose of 80 milligrams per square meter (mg/m\^2) as IV infusion QW for 3 cycles.
Placebo
Participants will receive placebo (matching to ipatasertib) orally daily on Days 1-21 of each 28-day cycle for 3 cycles.
Hospital San Pedro De Alcantara; Servicio de Oncologia, Cáceres
Hospital Provincial de Castellon; Servicio de Oncologia, Castellon
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia, Santiago de Compostela
Hospital Universitari de Girona Dr. Josep Trueta; Servicio de Oncologia, Girona
Hospital Universitari de Lleida Arnau de Vilanova, Lleida
Centro Oncologico MD Anderson International Espana, Madrid
Fundacion Jimenez Diaz; Servicio de Oncologia, Madrid
Hospital Universitario Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid
Centro Integral Oncologico Clara Campal (CIOCC); Dirección Médica, Madrid
Carolinas Healthcare System, Charlotte
Hospital Quiron de Madrid; Servicio de Oncologia, Madrid
Hospital Universitario Fundación Alcorcón, Alcorcón (Madrid)
Hospital Rey Juan Carlos; Pharmacy, Móstoles
Hospital Universitario de Fuenlabrada; Servicio de Oncologia, Madrid
Hospital Regional Universitario Carlos Haya; hospital Materno Infantil, servicio de Farmacia, Málaga
Roper Bon Secours St. Francis Cancer Center, Charleston
Hospital Virgen del Rocio, Seville
Hospital Universitario Virgen Macarena, Seville
Hospital Universitari Sant Joan de Reus; Servicio de Oncologia, Reus
Hospital Clinico Universitario; Oncologia, Valencia
Nebraska Cancer Specialists; Oncology Hematology West, PC, Omaha
Texas Oncology-Tyler, Irving
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology - Houston (Gessner), Houston
South Texas Cancer Center - McAllen, McAllen
Texas Oncology, Austin
Texas Oncology Cancer Center, Austin
Rocky Mountain Cancer Center - Lakewood (West), Lakewood
Arizona Oncology Associates, PC-CASA, Tucson
Sansum Medical Clinic, Inc., Santa Barbara
Northwest Cancer Specialists - Portland (NE Hoyt St), Portland
Northwest Medical Specialties, PLLC, Tacoma
Massachusetts General Hospital, Boston
Mass General/North Shore Cancer, Danvers
IPO de Lisboa; Servico de Oncologia Medica, Lisbon
Hospital Beatriz Angelo; Departamento de Oncologia, Loures
IPO do Porto; Servico de Oncologia Medica, Porto
Hospital Universitario Son Espases, Palma de Mallorca
Hospital Son Llatzer; Servicio de Oncologia, Palma de Mallorca
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona
Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona
Lead Sponsor
SOLTI Breast Cancer Research Group
OTHER
Genentech, Inc.
INDUSTRY